Invesco’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.93B | Buy |
10,177,013
+73,264
| +0.7% | +$13.8M | 0.15% | 102 |
|
|
2026
Q1 | $1.99B | Buy |
10,103,749
+1,343,372
| +15% | +$259M | 0.19% | 88 |
|
|
2025
Q4 | $1.61B | Buy |
8,760,377
+6,662,228
| +318% | +$1.17B | 0.15% | 112 |
|
|
2025
Q3 | $322M | Buy |
2,098,149
+167,544
| +9% | +$25.4M | 0.05% | 449 |
|
|
2025
Q2 | $270M | Buy |
1,930,605
+26,844
| +1% | +$3.76M | 0.05% | 502 |
|
|
2025
Q1 | $280M | Buy |
1,903,761
+474,329
| +33% | +$68.6M | 0.05% | 472 |
|
|
2024
Q4 | $187M | Sell |
1,429,432
-39,093
| -3% | -$5.47M | 0.03% | 651 |
|
|
2024
Q3 | $229M | Sell |
1,468,525
-140,037
| -9% | -$22.6M | 0.04% | 553 |
|
|
2024
Q2 | $251M | Buy |
1,608,562
+149,372
| +10% | +$22.5M | 0.05% | 472 |
|
|
2024
Q1 | $198M | Sell |
1,459,190
-186,440
| -11% | -$24.7M | 0.04% | 583 |
|
|
2023
Q4 | $222M | Sell |
1,645,630
-793,987
| -33% | -$103M | 0.05% | 504 |
|
|
2023
Q3 | $330M | Sell |
2,439,617
-441,327
| -15% | -$60.3M | 0.09% | 291 |
|
|
2023
Q2 | $412M | Sell |
2,880,944
-584,798
| -17% | -$86M | 0.11% | 235 |
|
|
2023
Q1 | $481M | Buy |
3,465,742
+449,090
| +15% | +$60.4M | 0.13% | 173 |
|
|
2022
Q4 | $409M | Sell |
3,016,652
-241,646
| -7% | -$30.3M | 0.12% | 211 |
|
|
2022
Q3 | $357M | Buy |
3,258,298
+149,721
| +5% | +$19M | 0.12% | 216 |
|
|
2022
Q2 | $411M | Sell |
3,108,577
-494,990
| -14% | -$64.9M | 0.12% | 194 |
|
|
2022
Q1 | $478M | Buy |
3,603,567
+118,848
| +3% | +$14.3M | 0.12% | 190 |
|
|
2021
Q4 | $406M | Sell |
3,484,719
-384,636
| -10% | -$45.3M | 0.1% | 264 |
|
|
2021
Q3 | $465M | Sell |
3,869,355
-926,819
| -19% | -$108M | 0.12% | 209 |
|
|
2021
Q2 | $575M | Sell |
4,796,174
-9,937
| -0.2% | -$1.09M | 0.14% | 165 |
|
|
2021
Q1 | $478M | Buy |
4,806,111
+231,470
| +5% | +$23.3M | 0.13% | 190 |
|
|
2020
Q4 | $457M | Sell |
4,574,641
-61,818
| -1% | -$6.55M | 0.13% | 176 |
|
|
2020
Q3 | $508M | Sell |
4,636,459
-474,235
| -9% | -$52.7M | 0.17% | 126 |
|
|
2020
Q2 | $541M | Sell |
5,110,694
-302,310
| -6% | -$31.2M | 0.19% | 111 |
|
|
2020
Q1 | $483M | Buy |
5,413,004
+1,053,033
| +24% | +$99.1M | 0.2% | 105 |
|
|
2019
Q4 | $435M | Sell |
4,359,971
-20,641
| -0.5% | -$1.94M | 0.14% | 175 |
|
|
2019
Q3 | $390M | Buy |
4,380,612
+1,726,021
| +65% | +$150M | 0.1% | 220 |
|
|
2019
Q2 | $219M | Buy |
2,654,591
+1,808,997
| +214% | +$142M | 0.06% | 394 |
|
|
2019
Q1 | $68.4M | Sell |
845,594
-5,540
| -0.7% | -$437K | 0.02% | 692 |
|
|
2018
Q4 | $64.7M | Sell |
851,134
-3,557
| -0.4% | -$278K | 0.02% | 645 |
|
|
2018
Q3 | $67.6M | Sell |
854,691
-70,468
| -8% | -$5.33M | 0.02% | 728 |
|
|
2018
Q2 | $65M | Buy |
925,159
+19,103
| +2% | +$1.37M | 0.02% | 727 |
|
|
2018
Q1 | $63.4M | Buy |
906,056
+504,239
| +125% | +$34.9M | 0.02% | 645 |
|
|
2017
Q4 | $27.9M | Sell |
401,817
-3,080
| -0.8% | -$208K | 0.01% | 1038 |
|
|
2017
Q3 | $27.4M | Sell |
404,897
-8,725
| -2% | -$551K | 0.01% | 1034 |
|
|
2017
Q2 | $28.2M | Sell |
413,622
-5,535
| -1% | -$361K | 0.01% | 1037 |
|
|
2017
Q1 | $26.1M | Sell |
419,157
-7,642
| -2% | -$445K | 0.01% | 1064 |
|
|
2016
Q4 | $23.3M | Buy |
426,799
+371,915
| +678% | +$21.1M | 0.01% | 1095 |
|
|
2016
Q3 | $3.61M | Sell |
54,884
-1,735
| -3% | -$113K | ﹤0.01% | 2188 |
|
|
2016
Q2 | $3.42M | Sell |
56,619
-651,668
| -92% | -$37.9M | ﹤0.01% | 2169 |
|
|
2016
Q1 | $39.9M | Sell |
708,287
-20,912
| -3% | -$1.26M | 0.02% | 848 |
|
|
2015
Q4 | $49.5M | Sell |
729,199
-415,582
| -36% | -$27.2M | 0.02% | 759 |
|
|
2015
Q3 | $72.9M | Sell |
1,144,781
-19,974
| -2% | -$1.31M | 0.03% | 594 |
|
|
2015
Q2 | $74.2M | Buy |
1,164,755
+416,322
| +56% | +$28.5M | 0.03% | 627 |
|
|
2015
Q1 | $51.2M | Buy |
748,433
+613,237
| +454% | +$42.6M | 0.02% | 802 |
|
|
2014
Q4 | $9.52M | Sell |
135,196
-14,352
| -10% | -$1.03M | ﹤0.01% | 1550 |
|
|
2014
Q3 | $10.7M | Buy |
149,548
+847
| +0.6% | +$62K | ﹤0.01% | 1505 |
|
|
2014
Q2 | $11.1M | Sell |
148,701
-1,777
| -1% | -$128K | ﹤0.01% | 1504 |
|
|
2014
Q1 | $9.76M | Sell |
150,478
-564,278
| -79% | -$36.4M | ﹤0.01% | 1531 |
|
|
2013
Q4 | $42.4M | Sell |
714,756
-121,589
| -15% | -$6.61M | 0.02% | 873 |
|
|
2013
Q3 | $43.4M | Buy |
836,345
+115,749
| +16% | +$5.81M | 0.02% | 829 |
|
|
2013
Q2 | $34.1M | Buy |
+720,596
| New | +$36.7M | 0.02% | 888 |
|
Other funds holding AZN
EP
IA
Invesco's AZN Position: Q2 2026 in Review
Invesco increased its AstraZeneca (AZN) stake by 0.73% in Q2 2026, buying an estimated $13.8M and bringing the position to 10,177,013 shares worth $1.93B. The position accounts for 0.15% of the portfolio, ranked #102.
Invesco first reported a position in AZN in Q2 2013 and has held it in 53 quarters since. The position peaked at $1.99B in Q1 2026. 1,495 funds tracked by Wall St. Rank hold AZN as of Q2 2026.
- Invesco held 10,177,013 shares of AstraZeneca worth $1.93B as of Q2 2026.
- Invesco bought 73,264 AstraZeneca shares in Q2 2026, an estimated $13.8M.
- AstraZeneca made up 0.15% of Invesco's portfolio in Q2 2026, its #102 holding.
- Invesco first reported a position in AstraZeneca in Q2 2013 and has held it in 53 quarters since.
- Invesco's AstraZeneca position peaked at $1.99B in Q1 2026.
- 1,495 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.
Based on Invesco's 13F filing for Q2 2026, filed 14 Aug 2026.